Advanced Age Is Associated with Poorer Bladder Cancer-Specific Survival in Patients Treated with Radical Cystectomy

Matthew E. Nielsen, Shahrokh F. Shariat, Pierre I. Karakiewicz, Yair Lotan, Craig G. Rogers, Gilad E. Amiel, Patrick J. Bastian, Amnon Vazina, Amit Gupta, Seth P. Lerner, Arthur I. Sagalowsky, Mark P. Schoenberg, Ganesh S. Palapattu

Research output: Contribution to journalArticle

113 Citations (Scopus)

Abstract

Objective: Bladder cancer (BCa) is a disease of older persons, the incidence of which is expected to increase as the population ages. There is controversy, however, regarding the outcomes of radical cystectomy (RC), the gold standard treatment of high-risk BCa, in patients of advanced chronological age. The aim of our study was to assess the impact of patient age on pathological characteristics and recurrence-free and disease-specific survival following RC. Methods: The records of 888 consecutive patients who underwent RC for transitional cell carcinoma (TCC) were reviewed. Age at RC was analyzed both as a continuous (yr) and categorical (≤60 yr old, n = 240; 60.1-70 yr old, n = 331; 70.1-80 yr old, n = 266; >80 yr old, n = 51) variable. Logistic regression and survival analyses were performed. Results: Higher age at RC, analyzed as a continuous or categorical variable, was associated with extravesical disease and pathological upstaging (all p < 0.02). Older patients were less likely to receive postoperative chemotherapy (≤60 yr: 32% vs. >80 yr: 14%, p = 0.008). In both pre- and postoperative multivariate models, higher age at RC as a categorical variable was associated with BCa-specific survival (p < 0.05). Patients >80 yr old had a significantly greater risk of disease recurrence than patients aged ≤60 yr (p < 0.05). Conclusion: Greater patient age at the time of RC for BCa is independently associated with adverse outcomes. Better understanding of factors associated with postoperative outcomes in this growing segment of the population is necessary. Prospective corroboration and further refinement of similar analyses in other large datasets is needed.

Original languageEnglish (US)
Pages (from-to)699-708
Number of pages10
JournalEuropean Urology
Volume51
Issue number3
DOIs
StatePublished - Mar 2007
Externally publishedYes

Fingerprint

Cystectomy
Urinary Bladder Neoplasms
Survival
Recurrence
Transitional Cell Carcinoma
Survival Analysis
Population
Disease-Free Survival
Logistic Models
Regression Analysis
Incidence

Keywords

  • Age
  • Bladder cancer
  • Cystectomy
  • Recurrence
  • Survival

ASJC Scopus subject areas

  • Urology

Cite this

Nielsen, M. E., Shariat, S. F., Karakiewicz, P. I., Lotan, Y., Rogers, C. G., Amiel, G. E., ... Palapattu, G. S. (2007). Advanced Age Is Associated with Poorer Bladder Cancer-Specific Survival in Patients Treated with Radical Cystectomy. European Urology, 51(3), 699-708. https://doi.org/10.1016/j.eururo.2006.11.004

Advanced Age Is Associated with Poorer Bladder Cancer-Specific Survival in Patients Treated with Radical Cystectomy. / Nielsen, Matthew E.; Shariat, Shahrokh F.; Karakiewicz, Pierre I.; Lotan, Yair; Rogers, Craig G.; Amiel, Gilad E.; Bastian, Patrick J.; Vazina, Amnon; Gupta, Amit; Lerner, Seth P.; Sagalowsky, Arthur I.; Schoenberg, Mark P.; Palapattu, Ganesh S.

In: European Urology, Vol. 51, No. 3, 03.2007, p. 699-708.

Research output: Contribution to journalArticle

Nielsen, ME, Shariat, SF, Karakiewicz, PI, Lotan, Y, Rogers, CG, Amiel, GE, Bastian, PJ, Vazina, A, Gupta, A, Lerner, SP, Sagalowsky, AI, Schoenberg, MP & Palapattu, GS 2007, 'Advanced Age Is Associated with Poorer Bladder Cancer-Specific Survival in Patients Treated with Radical Cystectomy', European Urology, vol. 51, no. 3, pp. 699-708. https://doi.org/10.1016/j.eururo.2006.11.004
Nielsen, Matthew E. ; Shariat, Shahrokh F. ; Karakiewicz, Pierre I. ; Lotan, Yair ; Rogers, Craig G. ; Amiel, Gilad E. ; Bastian, Patrick J. ; Vazina, Amnon ; Gupta, Amit ; Lerner, Seth P. ; Sagalowsky, Arthur I. ; Schoenberg, Mark P. ; Palapattu, Ganesh S. / Advanced Age Is Associated with Poorer Bladder Cancer-Specific Survival in Patients Treated with Radical Cystectomy. In: European Urology. 2007 ; Vol. 51, No. 3. pp. 699-708.
@article{19db91d5895a4a1f9b90227b9c308205,
title = "Advanced Age Is Associated with Poorer Bladder Cancer-Specific Survival in Patients Treated with Radical Cystectomy",
abstract = "Objective: Bladder cancer (BCa) is a disease of older persons, the incidence of which is expected to increase as the population ages. There is controversy, however, regarding the outcomes of radical cystectomy (RC), the gold standard treatment of high-risk BCa, in patients of advanced chronological age. The aim of our study was to assess the impact of patient age on pathological characteristics and recurrence-free and disease-specific survival following RC. Methods: The records of 888 consecutive patients who underwent RC for transitional cell carcinoma (TCC) were reviewed. Age at RC was analyzed both as a continuous (yr) and categorical (≤60 yr old, n = 240; 60.1-70 yr old, n = 331; 70.1-80 yr old, n = 266; >80 yr old, n = 51) variable. Logistic regression and survival analyses were performed. Results: Higher age at RC, analyzed as a continuous or categorical variable, was associated with extravesical disease and pathological upstaging (all p < 0.02). Older patients were less likely to receive postoperative chemotherapy (≤60 yr: 32{\%} vs. >80 yr: 14{\%}, p = 0.008). In both pre- and postoperative multivariate models, higher age at RC as a categorical variable was associated with BCa-specific survival (p < 0.05). Patients >80 yr old had a significantly greater risk of disease recurrence than patients aged ≤60 yr (p < 0.05). Conclusion: Greater patient age at the time of RC for BCa is independently associated with adverse outcomes. Better understanding of factors associated with postoperative outcomes in this growing segment of the population is necessary. Prospective corroboration and further refinement of similar analyses in other large datasets is needed.",
keywords = "Age, Bladder cancer, Cystectomy, Recurrence, Survival",
author = "Nielsen, {Matthew E.} and Shariat, {Shahrokh F.} and Karakiewicz, {Pierre I.} and Yair Lotan and Rogers, {Craig G.} and Amiel, {Gilad E.} and Bastian, {Patrick J.} and Amnon Vazina and Amit Gupta and Lerner, {Seth P.} and Sagalowsky, {Arthur I.} and Schoenberg, {Mark P.} and Palapattu, {Ganesh S.}",
year = "2007",
month = "3",
doi = "10.1016/j.eururo.2006.11.004",
language = "English (US)",
volume = "51",
pages = "699--708",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Advanced Age Is Associated with Poorer Bladder Cancer-Specific Survival in Patients Treated with Radical Cystectomy

AU - Nielsen, Matthew E.

AU - Shariat, Shahrokh F.

AU - Karakiewicz, Pierre I.

AU - Lotan, Yair

AU - Rogers, Craig G.

AU - Amiel, Gilad E.

AU - Bastian, Patrick J.

AU - Vazina, Amnon

AU - Gupta, Amit

AU - Lerner, Seth P.

AU - Sagalowsky, Arthur I.

AU - Schoenberg, Mark P.

AU - Palapattu, Ganesh S.

PY - 2007/3

Y1 - 2007/3

N2 - Objective: Bladder cancer (BCa) is a disease of older persons, the incidence of which is expected to increase as the population ages. There is controversy, however, regarding the outcomes of radical cystectomy (RC), the gold standard treatment of high-risk BCa, in patients of advanced chronological age. The aim of our study was to assess the impact of patient age on pathological characteristics and recurrence-free and disease-specific survival following RC. Methods: The records of 888 consecutive patients who underwent RC for transitional cell carcinoma (TCC) were reviewed. Age at RC was analyzed both as a continuous (yr) and categorical (≤60 yr old, n = 240; 60.1-70 yr old, n = 331; 70.1-80 yr old, n = 266; >80 yr old, n = 51) variable. Logistic regression and survival analyses were performed. Results: Higher age at RC, analyzed as a continuous or categorical variable, was associated with extravesical disease and pathological upstaging (all p < 0.02). Older patients were less likely to receive postoperative chemotherapy (≤60 yr: 32% vs. >80 yr: 14%, p = 0.008). In both pre- and postoperative multivariate models, higher age at RC as a categorical variable was associated with BCa-specific survival (p < 0.05). Patients >80 yr old had a significantly greater risk of disease recurrence than patients aged ≤60 yr (p < 0.05). Conclusion: Greater patient age at the time of RC for BCa is independently associated with adverse outcomes. Better understanding of factors associated with postoperative outcomes in this growing segment of the population is necessary. Prospective corroboration and further refinement of similar analyses in other large datasets is needed.

AB - Objective: Bladder cancer (BCa) is a disease of older persons, the incidence of which is expected to increase as the population ages. There is controversy, however, regarding the outcomes of radical cystectomy (RC), the gold standard treatment of high-risk BCa, in patients of advanced chronological age. The aim of our study was to assess the impact of patient age on pathological characteristics and recurrence-free and disease-specific survival following RC. Methods: The records of 888 consecutive patients who underwent RC for transitional cell carcinoma (TCC) were reviewed. Age at RC was analyzed both as a continuous (yr) and categorical (≤60 yr old, n = 240; 60.1-70 yr old, n = 331; 70.1-80 yr old, n = 266; >80 yr old, n = 51) variable. Logistic regression and survival analyses were performed. Results: Higher age at RC, analyzed as a continuous or categorical variable, was associated with extravesical disease and pathological upstaging (all p < 0.02). Older patients were less likely to receive postoperative chemotherapy (≤60 yr: 32% vs. >80 yr: 14%, p = 0.008). In both pre- and postoperative multivariate models, higher age at RC as a categorical variable was associated with BCa-specific survival (p < 0.05). Patients >80 yr old had a significantly greater risk of disease recurrence than patients aged ≤60 yr (p < 0.05). Conclusion: Greater patient age at the time of RC for BCa is independently associated with adverse outcomes. Better understanding of factors associated with postoperative outcomes in this growing segment of the population is necessary. Prospective corroboration and further refinement of similar analyses in other large datasets is needed.

KW - Age

KW - Bladder cancer

KW - Cystectomy

KW - Recurrence

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=33846209208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846209208&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2006.11.004

DO - 10.1016/j.eururo.2006.11.004

M3 - Article

VL - 51

SP - 699

EP - 708

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 3

ER -